A Cambridge, Mass., biotech says it has signed a deal with Swiss drug giant Roche (ROG) to develop new medicines to combat drug-resistant “superbugs,” three weeks after the World Health Organization said the world is running out of effective antibiotics.
Warp Drive Bio has been working for over a year to identify more than 100 new classes of potential antibiotics, using what it calls “genome mining platform” — including a vast database of genetic material that corresponds to more than 135,000 bacterial strains.
